Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy
0
Authors
Barry Maron
Barry Maron•Adrian Almquist•Sandro Betocchi
Published
February 10, 2000
Abstract
Hypertrophic cardiomyopathy is a genetic disease associated with a risk of ventricular tachyarrhythmias and sudden death, especially in young patients.
